| Literature DB >> 28050311 |
P Natteru1, M R Mohebbi2, P George3, D Wisco3, J Gebel4, C R Newey1.
Abstract
Introduction. Strokes and stroke-mimics have been extensively studied in the emergency department setting. Although in-hospital strokes are less studied in comparison to strokes in the emergency department, they are a source of significant direct and indirect costs. Differentiating in-hospital strokes from stroke-mimics is important. Thus, our study aimed to identify variables that can differentiate in-hospital strokes from stroke-mimics. Methods. We present here a retrospective analysis of 93 patients over a one-year period (2009 to 2010), who were evaluated for a concern of in-hospital strokes. Results. About two-thirds (57) of these patients were determined to have a stroke, and the remaining (36) were stroke-mimics. Patients with in-hospital strokes were more likely to be obese (p = 0.03), have been admitted to the cardiology service (p = 0.01), have atrial fibrillation (p = 0.03), have a weak hand or hemiparesis (p = 0.03), and have a prior history of stroke (p = 0.05), whereas, when the consults were called for "altered mental status" but no other deficits (p < 0.0001), it is likely a stroke-mimic. Conclusion. This study demonstrates that in-hospital strokes are a common occurrence, and knowing the variables can aid in their timely diagnosis and treatment.Entities:
Year: 2016 PMID: 28050311 PMCID: PMC5168479 DOI: 10.1155/2016/4393127
Source DB: PubMed Journal: Stroke Res Treat
Patient characteristics of strokes and stroke-mimics.
| All patients | Stroke patients only | Mimics only | ||||
|---|---|---|---|---|---|---|
|
|
|
| ||||
| Age, y, mean ± SD | 69.6 ± 12.9 | 69.6 ± 13.8 | 69.5 ± 11.7 | |||
| Male, | 42 | 45.2 | 24 | 42.1 | 18 | 50.0 |
| Hrs from onset, mean ± SD | 26.5 ± 123.8 | 38.2 ± 157.2 | 8.02 ± 15.0 | |||
|
| ||||||
| HTN, | 64 | 68.8 | 37 | 64.9 | 27 | 75 |
| Diabetes mellitus, | 23 | 24.7 | 13 | 22.8 | 10 | 27.8 |
| Hypercholesterolemia, | 43 | 46.2 | 22 | 38.6 | 21 | 58.3 |
| Atrial fibrillation, | 39 | 41.9 | 29 | 50.9 | 10 | 27.8 |
| CAD, | 48 | 51.6 | 28 | 49.1 | 20 | 55.6 |
| Past tobacco abuse, | 44 | 47.3 | 24 | 42.1 | 20 | 55.6 |
| Cancer, | 15 | 16.1 | 7 | 12.3 | 8 | 22.2 |
| Prior stroke, | 19 | 20.4 | 8 | 14 | 11 | 30.6 |
| Prior heart surgery, | 38 | 40.9 | 24 | 42.1 | 14 | 38.9 |
| Obesity, | 15 | 16.1 | 13 | 22.8 | 2 | 5.6 |
| Family history of stroke, | 17 | 18.3 | 10 | 17.5 | 7 | 19.4 |
|
| ||||||
| Awoke from sleep, | 18 | 19.4 | 13 | 22.8 | 5 | 13.9 |
| Coma, | 10 | 10.8 | 6 | 10.5 | 4 | 11.1 |
| Altered mental status, | 33 | 35.3 | 12 | 21.1 | 21 | 58.3 |
| Weak hand, | 15 | 16.1 | 13 | 22.8 | 2 | 5.6 |
| Hemiparesis, | 28 | 30.1 | 22 | 38.6 | 6 | 16.7 |
| AMET/CMET involved, | 6 | 6.45 | 4 | 7.02 | 2 | 6 |
| 2CLOT activation by non-MD provider, | 59 | 63.4 | 37 | 64.9 | 22 | 61.1 |
| Cardiology, | 27 | 29 | 22 | 38.6 | 5 | 13.9 |
| Cardiothoracic surgery service, | 31 | 33.3 | 19 | 33.3 | 12 | 33.3 |
|
| ||||||
| Antiplatelet, | 59 | 63.4 | 35 | 61.4 | 24 | 66.7 |
| Anticoagulation, | 23 | 24.7 | 16 | 28.1 | 7 | 19.4 |
| Statin, | 35 | 37.6 | 20 | 35.1 | 15 | 41.7 |
|
| ||||||
| SBP, mean ± SD | 128 ± 26.6 | 131 ± 27.2 | 123 ± 25.1 | |||
| Pulse, mean ± SD | 82.3 ± 18.4 | 84.2 ± 18.8 | 79.3 ± 17.5 | |||
| Temperature (Celsius), mean ± SD | 36.5 ± 0.72 | 36.6 ± 0.75 | 36.2 ± 0.59 | |||
| Baseline NIHSS, median (range) | 10 | 0–41 | 10 | 0–41 | 11.5 | 0–35 |
| NIHSS ≤ 5, | 34 | 36.6 | 24 | 42.1 | 10 | 27.8 |
| MRS 0 to 2, | 66 | 71 | 41 | 71.9 | 25 | 69.4 |
|
| ||||||
| WBC, K/uL, mean ± SD | 10.5 ± 7.41 | 9.78 ± 3.78 | 11.7 ± 10.9 | |||
| Platelets, K/uL, mean ± SD | 177 ± 85.6 | 178 ± 93.5 | 175 ± 72.7 | |||
| Sodium, mmol/L, mean ± SD | 137 ± 4.32 | 138 ± 3.49 | 136 ± 5.29 | |||
| BUN, mg/dL, mean ± SD | 27.7 ± 18.8 | 26.7 ± 17.7 | 29.3 ± 20.6 | |||
| Creatinine, mg/dL, mean ± SD | 1.51 ± 1.19 | 1.43 ± 1.02 | 1.64 ± 1.42 | |||
| Glucose, mg/dL, mean ± SD | 123 ± 45.5 | 119 ± 33.5 | 129 ± 59.9 | |||
| Brain MRI, | 34 | 36.6 | 23 | 40.4 | 11 | 30.6 |
|
| ||||||
| Home, | 40 | 43 | 23 | 40.4 | 17 | 47.2 |
| Rehabilitation, | 40 | 43 | 25 | 43.9 | 15 | 41.7 |
| Death, | 13 | 14 | 9 | 15.8 | 4 | 11.1 |
p < 0.05 ; p < 0.0001.
CAD, coronary artery disease; HTN, hypertension; 2CLOT, in-hospital stroke alerting system, AMET/CMET, in-hospital code blue team; NIHSS, NIH Stroke Scale; MRS, Modified Rankin Scale.
Multivariate analysis.
| Variables | OR |
|
|---|---|---|
| Hemiparesis | 3.6 | 0.042 |
| NIHSS item 1b | 0.46 | 0.17 |
| Normal mental status | 0.28 | 0.34 |
| Subjective complaint of weak hand | 6.24 | 0.042 |
NIHSS, National Institute of Health Stroke Scale; OR, odds ratio.
Stroke mechanisms.
| Stroke mechanisms |
| % |
|---|---|---|
| Cardioembolic | 41 | 71.9 |
| Large vessel | 8 | 14.0 |
| Small vessel | 2 | 3.5 |
| Other etiologies | 4 | 7.0 |
| Cryptogenic | 2 | 3.5 |
n, number.
Etiologies of stroke-mimics.
| Stroke-mimics |
| % |
|---|---|---|
| Toxic/metabolic | 14 | 38.9 |
| Seizure | 8 | 22.2 |
| Syncope | 5 | 13.9 |
| Sepsis | 4 | 11.1 |
| Tumor | 1 | 2.8 |
| Peripheral neuropathy | 1 | 2.8 |
| Functional | 1 | 2.8 |
| Dementia | 1 | 2.8 |
| Spinal cord lesion | 1 | 2.8 |
| Vestibular | 0 | 0.0 |
| Migraine | 0 | 0.0 |
|
| ||
|
|
| % |
|
| ||
| Medication (opioid/benzo) | 4 | 28.6 |
| Hyponatremia | 2 | 14.3 |
| Pulmonary distress | 2 | 14.3 |
| Hepatic failure | 2 | 14.3 |
| Hyperglycemia | 1 | 7.1 |
| Renal/hyperuricemia | 1 | 7.1 |
| Hyperkalemia | 1 | 7.1 |
| Attempting IV line | 1 | 7.1 |
IV, intravenous; benzo, benzodiazepine; n, number.
In-hospital stroke times.
| Treated in-hospital strokes | Minutes | StDev |
|---|---|---|
| Stroke onset to neuro evaluation | 34.8 | 21.4 |
| Stroke onset to treatment | 236.6 | 65.1 |
| Stroke onset to CT | 67.6 | 27.7 |
| Neuro evaluation to CT | 32.8 | 10.4 |
| Neuro evaluation to needle | 213.8 | 83.7 |
StDev, standard deviation; neuro, neurological; CT, computed tomography.